Business Innovation Archive — Page 2 of 6

Three men stand at a conference booth beneath Vanderbilt Health banners; the man on the right gives a thumbs-up, with promotional materials and drinkware displayed in the foreground.
May 4, 2026

Vanderbilt Health highlights physician-led innovation and analytics startups at Becker’s 16th Annual Meeting

Three suited men stand in a hospital hallway beside a banner reading “BEST CHILDREN’S HOSPITALS,” “U.S. NEWS & WORLD REPORT,” and “NEONATOLOGY 2025–2026.”
April 16, 2026

Northern Ireland Minister of Health visits Vanderbilt Health   

Visit explores Vanderbilt Health’s innovation and community-based health care.

Clinician in surgical attire reviews lung imaging on monitors beside a cone-beam CT scanner during a biopsy procedure.
April 9, 2026

How robotic bronchoscopy helped a Georgia man avoid unnecessary lung surgery

Oncologist Mohamed Shanshal, MD, said robotic bronchoscopy significantly improves getting patients the appropriate treatment as soon as possible, reducing their anxiety and improving care.

Russelle Bradbury, Daniel Fabbri, PhD, Ken Holroyd, MD, MBA, and Jennifer Pietenpol, PhD, stand together indoors; Fabbri holds a star-shaped award.
March 25, 2026

Brock Innovator of the Year lecture: Daniel Fabbri wants to speed research and patient care  

The Brock Family Center for Applied Innovation sponsors campus lectures to celebrate award winners.

Headshot of John F. Manning Jr. wearing a dark blazer and light blue shirt against a softly lit brown studio background.
March 20, 2026

Medical Center Chief Operating Officer John Manning to retire at year’s end

During a career at Vanderbilt spanning more than a quarter century, Manning’s portfolio of responsibilities steadily increased so that now major parts of the enterprise are under his watch.

Rows of labeled blood collection tubes with purple caps arranged in a plastic tray, with barcodes visible on several tubes.
March 5, 2026

Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering

Dataset grows to more than 312,000 whole genomes with longitudinal clinical data. GSK is one of the first to lead a further expansion of 50,000 whole genomes paired with proteomic data.